FierceBiotech Jan 12, 2026 'An undoing of the scientific method': Flagship CEO warns of government threats to US biotech industry
FierceBiotech Jan 12, 2026 Ohio Bets on Workforce Training to Capture Boom in Biomanufacturing, Digital Health
FierceBiotech Jan 12, 2026 Quest Diagnostics highlights role of in vitro diagnostics in precision medicine
FierceBiotech Jan 9, 2026 AirNexis takes flight with $200M, links up with China pharma for COPD asset in $955M biobucks deal
FierceBiotech Jan 9, 2026 Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
FierceBiotech Jan 9, 2026 Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
FierceBiotech Jan 9, 2026 Illumina hires former NHGRI Director Eric Green as new chief medical officer
FierceBiotech Jan 9, 2026 Roche returns to MediLink with promise of $570M near-term payments for another ADC
FierceBiotech Jan 9, 2026 Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster
FierceBiotech Jan 8, 2026 Longtime Charles River leader Jim Foster to retire, with COO set to take the helm
FierceBiotech Jan 8, 2026 Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery